ITÖ®¼Ò 2 Ô 25 ÈÕÏûÂÌÔ´»·±£¿£¿£¿£¿£¿£¿£¿£¿Æ¼¼ÓÐÏÞ¹«Ë¾Ï¢£¬£¬£¬£¬£¬£¬£¬£¬Counterpoint Research ½ñÈÕÌåÏÖ£¬£¬£¬£¬£¬£¬£¬£¬È«ÇòÖÇÄÜÊÖ±íÊг¡ÔÚÂÄÀúÁË 2024 ÄêµÄήËõºóÓÚ 2025 ÄêÀÖ³ÉʵÏÖÁ¿¼ÛÆëÉý£º³ö»õÊýÄ¿ÔöÌí 4%¡¢ASP£¨Æ½¾ùµ¥¼Û£©ÉÏÕÇ 5%¡£¡£¡£¡£¡£¡£
ÆÊÎöʦ Anshika Jain ÌåÏÖ£¬£¬£¬£¬£¬£¬£¬£¬ÓÉÓÚ¿µ½¡ÓëÔ˶¯ÒâʶµÄÌáÉý£¬£¬£¬£¬£¬£¬£¬£¬ÏûºÄÕß¶ÔÖÇÄÜÊÖ±íµÄ¹¦Ð§ÐèÇóÓú¼Ó¸»ºñ£¬£¬£¬£¬£¬£¬£¬£¬Íƶ¯Á˲úÆ·Éý¼¶Óë¼ÛÇ®ÉÏÕÇ£º£¼200 ÃÀÔªÊг¡³ö»õÏ»¬ 9%£»£»£»£»£»£»200~400 ÃÀԪϸ·ÖÊг¡Ôö·ù¸ß´ï 48%£»£»£»£»£»£»¶ø¼´¼´ÊÇÔÚÈëÃż¶²úÆ·ÖУ¬£¬£¬£¬£¬£¬£¬£¬ASP Ò²ÓÐ 34% µÄÌáÉý¡£¡£¡£¡£¡£¡£Óë´Ëͬʱ£¬£¬£¬£¬£¬£¬£¬£¬Ö§³Ö·äÎÑÒÆ¶¯Í¨Ñ¶ÍøÂçµÄÐͺÅÌåÏÖºÃÓÚÊг¡ÕûÌå¡£¡£¡£¡£¡£¡£

¡ø ͼԴ£ºCounterpoint
¶ø°´Æ·ÅÆ»®·Ö£¬£¬£¬£¬£¬£¬£¬£¬ÖÇÄÜÊÖ±íµÄÎå´óÂÌÔ´»·±£¿£¿£¿£¿£¿£¿£¿£¿Æ¼¼ÓÐÏÞ¹«Ë¾ÆóÒµÈÔÊÇÆ»¹û¡¢»ªÎª¡¢Ð¡Ãס¢ÈýÐÇ¡¢Ð¡Ìì²Å (imoo)£¬£¬£¬£¬£¬£¬£¬£¬ÆäÖлªÎªµÄ³ö»õÁ¿·ºÆðÁË 30% µÄÏÔÖøÌáÉý£¬£¬£¬£¬£¬£¬£¬£¬ÈýÐÇÔòÊÇÍ·²¿¼ÓÈëÕßÖÐΨһ³ö»õïÔÌµÄÆ·ÅÆ¡£¡£¡£¡£¡£¡£